417 related articles for article (PubMed ID: 29305717)
1. Influence of Low-Molecular-Weight Excipients on the Phase Behavior of PVPVA64 Amorphous Solid Dispersions.
Lehmkemper K; Kyeremateng SO; Degenhardt M; Sadowski G
Pharm Res; 2018 Jan; 35(1):25. PubMed ID: 29305717
[TBL] [Abstract][Full Text] [Related]
2. Physical stability of API/polymer-blend amorphous solid dispersions.
Lehmkemper K; Kyeremateng SO; Bartels M; Degenhardt M; Sadowski G
Eur J Pharm Biopharm; 2018 Mar; 124():147-157. PubMed ID: 29269154
[TBL] [Abstract][Full Text] [Related]
3. Impact of Polymer Type and Relative Humidity on the Long-Term Physical Stability of Amorphous Solid Dispersions.
Lehmkemper K; Kyeremateng SO; Heinzerling O; Degenhardt M; Sadowski G
Mol Pharm; 2017 Dec; 14(12):4374-4386. PubMed ID: 29050468
[TBL] [Abstract][Full Text] [Related]
4. Long-Term Physical Stability of PVP- and PVPVA-Amorphous Solid Dispersions.
Lehmkemper K; Kyeremateng SO; Heinzerling O; Degenhardt M; Sadowski G
Mol Pharm; 2017 Jan; 14(1):157-171. PubMed ID: 28043133
[TBL] [Abstract][Full Text] [Related]
5. Mutual Impact of Phase Separation/Crystallization and Water Sorption in Amorphous Solid Dispersions.
Luebbert C; Wessner M; Sadowski G
Mol Pharm; 2018 Feb; 15(2):669-678. PubMed ID: 29309155
[TBL] [Abstract][Full Text] [Related]
6. Phase behavior of pharmaceutically relevant polymer/solvent mixtures.
Dohrn S; Luebbert C; Lehmkemper K; Kyeremateng SO; Degenhardt M; Sadowski G
Int J Pharm; 2020 Mar; 577():119065. PubMed ID: 31988034
[TBL] [Abstract][Full Text] [Related]
7. Influence of copolymer composition on the phase behavior of solid dispersions.
Prudic A; Kleetz T; Korf M; Ji Y; Sadowski G
Mol Pharm; 2014 Nov; 11(11):4189-98. PubMed ID: 25295846
[TBL] [Abstract][Full Text] [Related]
8. Influence of humidity on the phase behavior of API/polymer formulations.
Prudic A; Ji Y; Luebbert C; Sadowski G
Eur J Pharm Biopharm; 2015 Aug; 94():352-62. PubMed ID: 26117187
[TBL] [Abstract][Full Text] [Related]
9. Combining crystalline and polymeric excipients in API solid dispersions - Opportunity or risk?
Veith H; Wiechert F; Luebbert C; Sadowski G
Eur J Pharm Biopharm; 2021 Jan; 158():323-335. PubMed ID: 33296719
[TBL] [Abstract][Full Text] [Related]
10. Solvent influence on the phase behavior and glass transition of Amorphous Solid Dispersions.
Dohrn S; Luebbert C; Lehmkemper K; Kyeremateng SO; Degenhardt M; Sadowski G
Eur J Pharm Biopharm; 2021 Jan; 158():132-142. PubMed ID: 33212185
[TBL] [Abstract][Full Text] [Related]
11. Thermodynamic phase behavior of API/polymer solid dispersions.
Prudic A; Ji Y; Sadowski G
Mol Pharm; 2014 Jul; 11(7):2294-304. PubMed ID: 24870944
[TBL] [Abstract][Full Text] [Related]
12. Influence of excipients on solubility and dissolution of pharmaceuticals.
Paus R; Prudic A; Ji Y
Int J Pharm; 2015 May; 485(1-2):277-87. PubMed ID: 25749073
[TBL] [Abstract][Full Text] [Related]
13. Physical stability of hydroxypropyl methylcellulose-based amorphous solid dispersions: Experimental and computational study.
Iemtsev A; Hassouna F; Mathers A; Klajmon M; Dendisová M; Malinová L; Školáková T; Fulem M
Int J Pharm; 2020 Nov; 589():119845. PubMed ID: 32931845
[TBL] [Abstract][Full Text] [Related]
14. Viscosity of ASDs at humid conditions.
Wolbert F; Stecker J; Luebbert C; Sadowski G
Eur J Pharm Biopharm; 2020 Sep; 154():387-396. PubMed ID: 32717391
[TBL] [Abstract][Full Text] [Related]
15. Thermodynamic and kinetic evaluation of the impact of polymer excipients on storage stability of amorphous itraconazole.
Zhang S; Lee TWY; Chow AHL
Int J Pharm; 2019 Jan; 555():394-403. PubMed ID: 30513399
[TBL] [Abstract][Full Text] [Related]
16. Thermodynamic Modeling of the Amorphous Solid Dispersion-Water Interfacial Layer and Its Impact on the Release Mechanism.
Dohrn S; Kyeremateng SO; Bochmann E; Sobich E; Wahl A; Liepold B; Sadowski G; Degenhardt M
Pharmaceutics; 2023 May; 15(5):. PubMed ID: 37242781
[TBL] [Abstract][Full Text] [Related]
17. Moisture-induced phase separation and recrystallization in amorphous solid dispersions.
Luebbert C; Sadowski G
Int J Pharm; 2017 Oct; 532(1):635-646. PubMed ID: 28867448
[TBL] [Abstract][Full Text] [Related]
18. Micro-scale solubility assessments and prediction models for active pharmaceutical ingredients in polymeric matrices.
Bochmann ES; Neumann D; Gryczke A; Wagner KG
Eur J Pharm Biopharm; 2019 Aug; 141():111-120. PubMed ID: 31100430
[TBL] [Abstract][Full Text] [Related]
19. Can Pure Predictions of Activity Coefficients from PC-SAFT Assist Drug-Polymer Compatibility Screening?
Pavliš J; Mathers A; Fulem M; Klajmon M
Mol Pharm; 2023 Aug; 20(8):3960-3974. PubMed ID: 37386723
[TBL] [Abstract][Full Text] [Related]
20. Investigation of miscibility estimation methods between indomethacin and poly(vinylpyrrolidone-co-vinyl acetate).
Pezzoli R; Lyons JG; Gately N; Higginbotham CL
Int J Pharm; 2018 Oct; 549(1-2):50-57. PubMed ID: 30016675
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
